Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.
Publication
, Conference
McDonald, KL; Khasraw, M; Ashley, DM
Published in: Journal of Clinical Oncology
May 20, 2015
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
2071 / 2071
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McDonald, K. L., Khasraw, M., & Ashley, D. M. (2015). Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy. In Journal of Clinical Oncology (Vol. 33, pp. 2071–2071). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.2071
McDonald, Kerrie Leanne, Mustafa Khasraw, and David M. Ashley. “Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.” In Journal of Clinical Oncology, 33:2071–2071. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.2071.
McDonald KL, Khasraw M, Ashley DM. Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 2071–2071.
McDonald, Kerrie Leanne, et al. “Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 2071–2071. Crossref, doi:10.1200/jco.2015.33.15_suppl.2071.
McDonald KL, Khasraw M, Ashley DM. Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 2071–2071.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
2071 / 2071
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences